Intraosseous vascular access device for outpatient infusions
"This prospective, single-arm, first-in-human study evaluated the feasibility and safety of the fully subcutaneous IO device over a 7-day implant with daily infusions in patients with challenging venous access or CKD" Ulloa et al (2026).